Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 324

1.

Evaluation of the Frequency of "Not Relevant" Responses on the Dermatology Life Quality Index by Sociodemographic Characteristics of Patients With Psoriasis.

Barbieri JS, Shin DB, Syed MN, Takeshita J, Gelfand JM.

JAMA Dermatol. 2020 Feb 26. doi: 10.1001/jamadermatol.2019.4659. [Epub ahead of print]

PMID:
32101261
2.

A Randomized Placebo Controlled Trial of Secukinumab on Aortic Vascular Inflammation in Moderate to Severe Plaque Psoriasis (VIP-S).

Gelfand JM, Shin DB, Duffin KC, Armstrong AW, Blauvelt A, Tyring SK, Menter A, Gottlieb S, Lockshin BN, Simpson EL, Kianifard F, Sarkar RP, Muscianisi E, Steadman J, Ahlman MA, Playford MP, Joshi AA, Dey AK, Werner TJ, Alavi A, Mehta NN.

J Invest Dermatol. 2020 Feb 20. pii: S0022-202X(20)30157-3. doi: 10.1016/j.jid.2020.01.025. [Epub ahead of print]

PMID:
32088207
3.

Fixational microsaccades: A quantitative and objective measure of disability in multiple sclerosis.

Sheehy CK, Bensinger ES, Romeo A, Rani L, Stepien-Bernabe N, Shi B, Helft Z, Putnam N, Cordano C, Gelfand JM, Bove R, Stevenson SB, Green AJ.

Mult Scler. 2020 Feb 7:1352458519894712. doi: 10.1177/1352458519894712. [Epub ahead of print]

PMID:
32031464
4.

Intrathecal B-cell activation in LGI1 antibody encephalitis.

Lehmann-Horn K, Irani SR, Wang S, Palanichamy A, Jahn S, Greenfield AL, Dandekar R, Lepennetier G, Michael S, Gelfand JM, Geschwind MD, Wilson MR, Zamvil SS, von Büdingen HC.

Neurol Neuroimmunol Neuroinflamm. 2020 Feb 6;7(2). pii: e669. doi: 10.1212/NXI.0000000000000669. Print 2020 Mar.

5.

Exploratory analysis of the potential for advanced diagnostic testing to reduce healthcare expenditures of patients hospitalized with meningitis or encephalitis.

Fulton BD, Proudman DG, Sample HA, Gelfand JM, Chiu CY, DeRisi JL, Wilson MR.

PLoS One. 2020 Jan 15;15(1):e0226895. doi: 10.1371/journal.pone.0226895. eCollection 2020.

6.

Allogeneic HSCT for adult-onset leukoencephalopathy with spheroids and pigmented glia.

Gelfand JM, Greenfield AL, Barkovich M, Mendelsohn BA, Van Haren K, Hess CP, Mannis GN.

Brain. 2020 Feb 1;143(2):503-511. doi: 10.1093/brain/awz390.

PMID:
31840744
7.

Validation of a consumer-grade activity monitor for continuous daily activity monitoring in individuals with multiple sclerosis.

Block VJ, Zhao C, Hollenbach JA, Olgin JE, Marcus GM, Pletcher MJ, Henry R, Gelfand JM, Cree BA.

Mult Scler J Exp Transl Clin. 2019 Nov 21;5(4):2055217319888660. doi: 10.1177/2055217319888660. eCollection 2019 Oct-Dec.

8.

Association Between Soluble Lectinlike Oxidized Low-Density Lipoprotein Receptor-1 and Coronary Artery Disease in Psoriasis.

Dey AK, Gaddipati R, Elnabawi YA, Ongstad E, Goyal A, Chung JH, Teague HL, Rodante JA, Sajja AA, Sorokin AV, Lateef SS, Aksentijevich M, Choi H, Reddy AS, Varghese NJ, Groenendyk J, Belur AD, Genovese L, Rivers JP, Lerman J, Kabbany MT, Harrington C, Ortiz J, Khalil N, Keel A, Baumer Y, Chen MY, Bluemke DA, Joshi AA, Kaplan MJ, Remaley AT, Playford MP, Karathanasis SK, Gelfand JM, Gupta R, Mehta NN.

JAMA Dermatol. 2019 Nov 20. doi: 10.1001/jamadermatol.2019.3595. [Epub ahead of print]

PMID:
31746956
9.

Responsiveness to Change and Establishment of the Minimal Clinically Important Difference for the Cutaneous Sarcoidosis Activity and Morphology Instrument.

Noe MH, Gelfand JM, Bryer JS, Price SN, Judson MA, Rosenbach M.

JAMA Dermatol. 2019 Nov 13. doi: 10.1001/jamadermatol.2019.3519. [Epub ahead of print] No abstract available.

PMID:
31721981
10.

Joint American Academy of Dermatology-National Psoriasis Foundation guidelines of care for the management and treatment of psoriasis in pediatric patients.

Menter A, Cordoro KM, Davis DMR, Kroshinsky D, Paller AS, Armstrong AW, Connor C, Elewski BE, Gelfand JM, Gordon KB, Gottlieb AB, Kaplan DH, Kavanaugh A, Kiselica M, Kivelevitch D, Korman NJ, Lebwohl M, Leonardi CL, Lichten J, Lim HW, Mehta NN, Parra SL, Pathy AL, Farley Prater EA, Rupani RN, Siegel M, Stoff B, Strober BE, Wong EB, Wu JJ, Hariharan V, Elmets CA.

J Am Acad Dermatol. 2020 Jan;82(1):161-201. doi: 10.1016/j.jaad.2019.08.049. Epub 2019 Nov 5. Erratum in: J Am Acad Dermatol. 2020 Mar;82(3):574.

PMID:
31703821
11.

Application of Machine Learning to Determine Top Predictors of Non-calcified Coronary Burden in Psoriasis: an Observational Cohort Study.

Munger E, Choi H, Dey AK, Elnabawi YA, Groenendyk JW, Rodante J, Keel A, Aksentijevich M, Reddy AS, Khalil N, Argueta-Ameya J, Playford MP, Erb-Alvarez J, Tian X, Wu C, Gudjonsson JE, Tsoi LC, Jafri MS, Sandfort V, Chen MY, Shah SJ, Bluemke DA, Lockshin B, Hasan A, Gelfand JM, Mehta NN.

J Am Acad Dermatol. 2019 Oct 30. pii: S0190-9622(19)32983-4. doi: 10.1016/j.jaad.2019.10.060. [Epub ahead of print]

PMID:
31678339
12.

Mental health impairment among children with atopic dermatitis: a U.S. population-based cross-sectional study of the 2013-2017 National Health Interview Survey.

Wan J, Takeshita J, Shin DB, Gelfand JM.

J Am Acad Dermatol. 2019 Oct 15. pii: S0190-9622(19)32902-0. doi: 10.1016/j.jaad.2019.10.019. [Epub ahead of print]

PMID:
31626880
13.

Cells of Myeloid Origin Partly Mediate the Association between Psoriasis Severity and Coronary Plaque.

Teague HL, Aksentijevich M, Stansky E, Silverman JI, Varghese NJ, Dey AK, Elnabawi Y, Goyal A, Dagur PK, Chen MY, McCoy JP, Playford MP, Hourigan C, Gelfand JM, Mehta NN.

J Invest Dermatol. 2019 Sep 17. pii: S0022-202X(19)33234-8. doi: 10.1016/j.jid.2019.07.724. [Epub ahead of print] No abstract available.

PMID:
31539534
14.

Progressive Neurological Impairment and an Enhancing Brainstem Lesion in a Middle-aged Man.

Gupta S, Damon L, Gelfand JM.

JAMA Neurol. 2019 Sep 16. doi: 10.1001/jamaneurol.2019.3002. [Epub ahead of print] No abstract available.

PMID:
31524939
15.

Prescribing Patterns Associated With Biologic Therapies for Psoriasis from a United States Medical Records Database

Noe MH, Shin DB, Doshi JA, Margolis DJ, Gelfand JM.

J Drugs Dermatol. 2019 Aug 1;18(8):745-750.

16.

Association of aortic vascular uptake of 18FDG by PET/CT and aortic wall thickness by MRI in psoriasis: a prospective observational study.

Groenendyk JW, Shukla P, Dey AK, Elnabawi YA, Aksentijevich M, Choi H, Genovese LD, Harrington CL, Natarajan B, Goyal A, Reddy AS, Rodante J, Kabbany MT, Sadek A, Al Najafi M, Playford MP, Joshi AA, Ahlman MA, Gelfand JM, Bluemke DA, Mehta NN.

Eur J Nucl Med Mol Imaging. 2019 Nov;46(12):2488-2495. doi: 10.1007/s00259-019-04454-w. Epub 2019 Aug 5.

PMID:
31385013
17.

Dupilumab shows long-term safety and efficacy in patients with moderate to severe atopic dermatitis enrolled in a phase 3 open-label extension study.

Deleuran M, Thaçi D, Beck LA, de Bruin-Weller M, Blauvelt A, Forman S, Bissonnette R, Reich K, Soong W, Hussain I, Foley P, Hide M, Bouaziz JD, Gelfand JM, Sher L, Schuttelaar MLA, Wang C, Chen Z, Akinlade B, Gadkari A, Eckert L, Davis JD, Rajadhyaksha M, Staudinger H, Graham NMH, Pirozzi G, Ardeleanu M.

J Am Acad Dermatol. 2020 Feb;82(2):377-388. doi: 10.1016/j.jaad.2019.07.074. Epub 2019 Jul 30.

18.

Association of Biologic Therapy With Coronary Inflammation in Patients With Psoriasis as Assessed by Perivascular Fat Attenuation Index.

Elnabawi YA, Oikonomou EK, Dey AK, Mancio J, Rodante JA, Aksentijevich M, Choi H, Keel A, Erb-Alvarez J, Teague HL, Joshi AA, Playford MP, Lockshin B, Choi AD, Gelfand JM, Chen MY, Bluemke DA, Shirodaria C, Antoniades C, Mehta NN.

JAMA Cardiol. 2019 Jul 31. doi: 10.1001/jamacardio.2019.2589. [Epub ahead of print]

PMID:
31365032
19.

Joint American Academy of Dermatology-National Psoriasis Foundation guidelines of care for the management and treatment of psoriasis with phototherapy.

Elmets CA, Lim HW, Stoff B, Connor C, Cordoro KM, Lebwohl M, Armstrong AW, Davis DMR, Elewski BE, Gelfand JM, Gordon KB, Gottlieb AB, Kaplan DH, Kavanaugh A, Kiselica M, Kivelevitch D, Korman NJ, Kroshinsky D, Leonardi CL, Lichten J, Mehta NN, Paller AS, Parra SL, Pathy AL, Farley Prater EA, Rupani RN, Siegel M, Strober BE, Wong EB, Wu JJ, Hariharan V, Menter A.

J Am Acad Dermatol. 2019 Sep;81(3):775-804. doi: 10.1016/j.jaad.2019.04.042. Epub 2019 Jul 25. Erratum in: J Am Acad Dermatol. 2020 Mar;82(3):780.

PMID:
31351884
20.

Multiple sclerosis and sarcoidosis: A case for coexistence.

Tyshkov C, Pawate S, Bradshaw MJ, Kimbrough DJ, Chitnis T, Gelfand JM, Ryerson LZ, Kister I.

Neurol Clin Pract. 2019 Jun;9(3):218-227. doi: 10.1212/CPJ.0000000000000629.

PMID:
31341709
21.

A Phase IV, Randomized, Double-Blind, Placebo-Controlled Crossover Study of the Effects of Ustekinumab on Vascular Inflammation in Psoriasis (the VIP-U Trial).

Gelfand JM, Shin DB, Alavi A, Torigian DA, Werner T, Papadopoulos M, Takeshita J, Noe MH, Dey AK, Playford MP, Mehta NN.

J Invest Dermatol. 2020 Jan;140(1):85-93.e2. doi: 10.1016/j.jid.2019.07.679. Epub 2019 Jul 19.

PMID:
31326395
22.

Exploratory proteomic analysis implicates the alternative complement cascade in primary CNS vasculitis.

Mandel-Brehm C, Retallack H, Knudsen GM, Yamana A, Hajj-Ali RA, Calabrese LH, Tihan T, Sample HA, Zorn KC, Gorman MP, Madan Cohen J, Sreih AG, Marcus JF, Josephson SA, Douglas VC, Gelfand JM, Wilson MR, DeRisi JL.

Neurology. 2019 Jul 30;93(5):e433-e444. doi: 10.1212/WNL.0000000000007850. Epub 2019 Jul 3.

PMID:
31270218
23.

Pain Is a Common and Burdensome Symptom of Atopic Dermatitis in United States Adults.

Silverberg JI, Gelfand JM, Margolis DJ, Boguniewicz M, Fonacier L, Grayson MH, Chiesa Fuxench ZC, Simpson EL, Ong PY.

J Allergy Clin Immunol Pract. 2019 Nov - Dec;7(8):2699-2706.e7. doi: 10.1016/j.jaip.2019.05.055. Epub 2019 Jun 20.

PMID:
31228619
24.

Clinical Metagenomic Sequencing for Diagnosis of Meningitis and Encephalitis.

Wilson MR, Sample HA, Zorn KC, Arevalo S, Yu G, Neuhaus J, Federman S, Stryke D, Briggs B, Langelier C, Berger A, Douglas V, Josephson SA, Chow FC, Fulton BD, DeRisi JL, Gelfand JM, Naccache SN, Bender J, Dien Bard J, Murkey J, Carlson M, Vespa PM, Vijayan T, Allyn PR, Campeau S, Humphries RM, Klausner JD, Ganzon CD, Memar F, Ocampo NA, Zimmermann LL, Cohen SH, Polage CR, DeBiasi RL, Haller B, Dallas R, Maron G, Hayden R, Messacar K, Dominguez SR, Miller S, Chiu CY.

N Engl J Med. 2019 Jun 13;380(24):2327-2340. doi: 10.1056/NEJMoa1803396.

25.

Factors Influencing Sleep Difficulty and Sleep Quantity in the Citizen Pscientist Psoriatic Cohort.

Smith MP, Ly K, Thibodeaux Q, Weerasinghe T, Beck K, Shankle L, Armstrong AW, Boas M, Bridges A, Doris F, Gelfand JM, Lafoy B, Orbai AM, Takeshita J, Truman S, Wan MT, Wu JJ, Siegel MP, Bell SJ, Bhutani T, Liao W.

Dermatol Ther (Heidelb). 2019 Sep;9(3):511-523. doi: 10.1007/s13555-019-0306-1. Epub 2019 Jun 8.

26.

Patient-reported outcomes of adalimumab, phototherapy, and placebo in the Vascular Inflammation in Psoriasis Trial: A randomized controlled study.

Noe MH, Wan MT, Shin DB, Armstrong AW, Duffin KC, Chiesa Fuxench ZC, Kalb RE, Menter A, Simpson EL, Takeshita J, Tyring SK, Van Voorhees AS, Mehta NN, Gelfand JM.

J Am Acad Dermatol. 2019 Oct;81(4):923-930. doi: 10.1016/j.jaad.2019.05.080. Epub 2019 Jun 1.

PMID:
31163241
27.

GABAA receptor autoimmunity: A multicenter experience.

O'Connor K, Waters P, Komorowski L, Zekeridou A, Guo CY, Mgbachi VC, Probst C, Mindorf S, Teegen B, Gelfand JM, Geschwind MD, Lennon V, Pittock SJ, McKeon A.

Neurol Neuroimmunol Neuroinflamm. 2019 Apr 4;6(3):e552. doi: 10.1212/NXI.0000000000000552. eCollection 2019 May.

28.

Responsiveness of the EuroQol 5-Dimension 3-Level instrument, Dermatology Life Quality Index (DLQI) and DLQI-Relevant for patients with psoriasis in the U.S.A.

Barbieri JS, Gelfand JM.

Br J Dermatol. 2019 Nov;181(5):1088-1090. doi: 10.1111/bjd.18142. Epub 2019 Aug 6. No abstract available.

PMID:
31102266
29.

Lack of association of biologic therapy for psoriasis with psychiatric illness: An electronic medical records cohort study.

Margolis DJ, Shin D, Noe MH, Wan MT, Bhate K, Wang S, Hoffstad O, Takeshita J, Gelfand JM.

J Am Acad Dermatol. 2019 Sep;81(3):709-716. doi: 10.1016/j.jaad.2019.04.055. Epub 2019 May 2.

PMID:
31054973
30.

Validation and Interpretation of Short Form 12 and Comparison with Dermatology Life Quality Index in Atopic Dermatitis in Adults.

Silverberg JI, Gelfand JM, Margolis DJ, Boguniewicz M, Fonacier L, Grayson MH, Ong PY, Chiesa Fuxench ZC, Simpson EL.

J Invest Dermatol. 2019 Oct;139(10):2090-2097.e3. doi: 10.1016/j.jid.2019.03.1152. Epub 2019 Apr 19.

PMID:
31009616
31.

Influence of "Not Relevant" Responses on the Dermatology Life Quality Index (DLQI) for Patients With Psoriasis in the United States.

Barbieri JS, Gelfand JM.

JAMA Dermatol. 2019 Jun 1;155(6):743-745. doi: 10.1001/jamadermatol.2018.5655. No abstract available.

PMID:
30969312
32.

Burden of illness in adults with atopic dermatitis: Analysis of National Health and Wellness Survey data from France, Germany, Italy, Spain, and the United Kingdom.

Eckert L, Gupta S, Gadkari A, Mahajan P, Gelfand JM.

J Am Acad Dermatol. 2019 Jul;81(1):187-195. doi: 10.1016/j.jaad.2019.03.037. Epub 2019 Mar 21.

33.

Distribution of atopic dermatitis lesions in United States adults.

Silverberg JI, Margolis DJ, Boguniewicz M, Fonacier L, Grayson MH, Ong PY, Chiesa Fuxench ZC, Simpson EL, Gelfand JM.

J Eur Acad Dermatol Venereol. 2019 Jul;33(7):1341-1348. doi: 10.1111/jdv.15574. Epub 2019 Apr 15.

PMID:
30883885
34.

Engaging the Patient's Perspective in Clinical Trials Research.

Hefele B, Langan SM, Pollins K, Gelfand JM.

J Invest Dermatol. 2019 Jun;139(6):1217-1220. doi: 10.1016/j.jid.2019.02.028. Epub 2019 Mar 14. No abstract available.

35.

Association of Continuous Assessment of Step Count by Remote Monitoring With Disability Progression Among Adults With Multiple Sclerosis.

Block VJ, Bove R, Zhao C, Garcha P, Graves J, Romeo AR, Green AJ, Allen DD, Hollenbach JA, Olgin JE, Marcus GM, Pletcher MJ, Cree BAC, Gelfand JM.

JAMA Netw Open. 2019 Mar 1;2(3):e190570. doi: 10.1001/jamanetworkopen.2019.0570.

36.

Silent progression in disease activity-free relapsing multiple sclerosis.

University of California, San Francisco MS-EPIC Team, Cree BAC, Hollenbach JA, Bove R, Kirkish G, Sacco S, Caverzasi E, Bischof A, Gundel T, Zhu AH, Papinutto N, Stern WA, Bevan C, Romeo A, Goodin DS, Gelfand JM, Graves J, Green AJ, Wilson MR, Zamvil SS, Zhao C, Gomez R, Ragan NR, Rush GQ, Barba P, Santaniello A, Baranzini SE, Oksenberg JR, Henry RG, Hauser SL.

Ann Neurol. 2019 May;85(5):653-666. doi: 10.1002/ana.25463. Epub 2019 Mar 30.

37.

Neutrophil Subsets, Platelets, and Vascular Disease in Psoriasis.

Teague HL, Varghese NJ, Tsoi LC, Dey AK, Garshick MS, Silverman JI, Baumer Y, Harrington CL, Stempinski E, Elnabawi YA, Dagur PK, Cui K, Tunc I, Seifuddin F, Joshi AA, Stansky E, Purmalek MM, Rodante JA, Keel A, Aridi TZ, Carmona-Rivera C, Sanda GE, Chen MY, Pirooznia M, McCoy JP Jr, Gelfand JM, Zhao K, Gudjonsson JE, Playford MP, Kaplan MJ, Berger JS, Mehta NN.

JACC Basic Transl Sci. 2019 Feb 25;4(1):1-14. doi: 10.1016/j.jacbts.2018.10.008. eCollection 2019 Feb.

38.

Development and Validation of a Risk Prediction Model for In-Hospital Mortality Among Patients With Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis-ABCD-10.

Noe MH, Rosenbach M, Hubbard RA, Mostaghimi A, Cardones AR, Chen JK, Cotliar J, Davis MDP, Dominguez A, Fox LP, Hughey LC, Kaffenberger BH, Kroshinsky D, Kwong BY, Miller DD, Musiek A, Ortega-Loayza AG, Sharon VR, Shinkai K, Summers EM, Wanat KA, Wetter DA, Worswick S, Margolis DJ, Gelfand JM, Micheletti RG.

JAMA Dermatol. 2019 Apr 1;155(4):448-454. doi: 10.1001/jamadermatol.2018.5605. Erratum in: JAMA Dermatol. 2019 Jul 31;:.

PMID:
30840032
39.

Symptoms and diagnosis of anxiety and depression in atopic dermatitis in U.S. adults.

Silverberg JI, Gelfand JM, Margolis DJ, Boguniewicz M, Fonacier L, Grayson MH, Ong PY, Chiesa Fuxench ZC, Simpson EL.

Br J Dermatol. 2019 Sep;181(3):554-565. doi: 10.1111/bjd.17683. Epub 2019 Mar 5.

40.

Clinic to in-home telemedicine reduces barriers to care for patients with MS or other neuroimmunologic conditions.

Bove R, Garcha P, Bevan CJ, Crabtree-Hartman E, Green AJ, Gelfand JM.

Neurol Neuroimmunol Neuroinflamm. 2018 Oct 2;5(6):e505. doi: 10.1212/NXI.0000000000000505. eCollection 2018 Nov.

41.

Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with biologics.

Menter A, Strober BE, Kaplan DH, Kivelevitch D, Prater EF, Stoff B, Armstrong AW, Connor C, Cordoro KM, Davis DMR, Elewski BE, Gelfand JM, Gordon KB, Gottlieb AB, Kavanaugh A, Kiselica M, Korman NJ, Kroshinsky D, Lebwohl M, Leonardi CL, Lichten J, Lim HW, Mehta NN, Paller AS, Parra SL, Pathy AL, Rupani RN, Siegel M, Wong EB, Wu JJ, Hariharan V, Elmets CA.

J Am Acad Dermatol. 2019 Apr;80(4):1029-1072. doi: 10.1016/j.jaad.2018.11.057. Epub 2019 Feb 13. Review.

PMID:
30772098
42.

Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with awareness and attention to comorbidities.

Elmets CA, Leonardi CL, Davis DMR, Gelfand JM, Lichten J, Mehta NN, Armstrong AW, Connor C, Cordoro KM, Elewski BE, Gordon KB, Gottlieb AB, Kaplan DH, Kavanaugh A, Kivelevitch D, Kiselica M, Korman NJ, Kroshinsky D, Lebwohl M, Lim HW, Paller AS, Parra SL, Pathy AL, Prater EF, Rupani R, Siegel M, Stoff B, Strober BE, Wong EB, Wu JJ, Hariharan V, Menter A.

J Am Acad Dermatol. 2019 Apr;80(4):1073-1113. doi: 10.1016/j.jaad.2018.11.058. Epub 2019 Feb 13. Review.

PMID:
30772097
43.

Racial Differences in Perceptions of Psoriasis Therapies: Implications for Racial Disparities in Psoriasis Treatment.

Takeshita J, Eriksen WT, Raziano VT, Bocage C, Hur L, Shah RV, Gelfand JM, Barg FK.

J Invest Dermatol. 2019 Aug;139(8):1672-1679.e1. doi: 10.1016/j.jid.2018.12.032. Epub 2019 Feb 6.

PMID:
30738054
44.

Coronary artery plaque characteristics and treatment with biologic therapy in severe psoriasis: results from a prospective observational study.

Elnabawi YA, Dey AK, Goyal A, Groenendyk JW, Chung JH, Belur AD, Rodante J, Harrington CL, Teague HL, Baumer Y, Keel A, Playford MP, Sandfort V, Chen MY, Lockshin B, Gelfand JM, Bluemke DA, Mehta NN.

Cardiovasc Res. 2019 Mar 15;115(4):721-728. doi: 10.1093/cvr/cvz009.

45.

pRNFL as a marker of disability worsening in the medium/long term in patients with MS.

Cordano C, Nourbakhsh B, Devereux M, Damotte V, Bennett D, Hauser SL, Cree BAC, Gelfand JM, Green AJ.

Neurol Neuroimmunol Neuroinflamm. 2018 Dec 21;6(2):e533. doi: 10.1212/NXI.0000000000000533. eCollection 2019 Mar. No abstract available.

46.

Atopic Dermatitis in US Adults: From Population to Health Care Utilization.

Silverberg JI, Gelfand JM, Margolis DJ, Boguniewicz M, Fonacier L, Grayson MH, Ong PY, Chiesa Fuxench Z, Simpson EL.

J Allergy Clin Immunol Pract. 2019 May - Jun;7(5):1524-1532.e2. doi: 10.1016/j.jaip.2019.01.005. Epub 2019 Jan 14.

PMID:
30654197
47.

Prevalence of clinically significant incidental findings by whole-body fludeoxyglucose F 18 positron emission tomography/computed tomography scanning in moderate-to-severe psoriasis patients participating in clinical trials.

Wan MT, Torigian DA, Alavi A, Alvarez J, Chiesa Fuxench ZC, Noe MH, Papadopoulos M, Shin DB, Takeshita J, Werner TJ, Mehta NN, Gelfand JM.

J Am Acad Dermatol. 2019 Jun;80(6):1630-1639. doi: 10.1016/j.jaad.2019.01.008. Epub 2019 Jan 14.

PMID:
30654078
48.

Effectiveness of Online vs In-Person Care for Adults With Psoriasis: A Randomized Clinical Trial.

Armstrong AW, Chambers CJ, Maverakis E, Cheng MY, Dunnick CA, Chren MM, Gelfand JM, Wong DJ, Gibbons BM, Gibbons CM, Torres J, Steel AC, Wang EA, Clark CM, Singh S, Kornmehl HA, Wilken R, Florek AG, Ford AR, Ma C, Ehsani-Chimeh N, Boddu S, Fujita M, Young PM, Rivas-Sanchez C, Cornejo BI, Serna LC, Carlson ER, Lane CJ.

JAMA Netw Open. 2018 Oct 5;1(6):e183062. doi: 10.1001/jamanetworkopen.2018.3062.

49.

Measurement Properties of the Hospital Anxiety and Depression Scale Used in Atopic Dermatitis in Adults.

Silverberg JI, Gelfand JM, Margolis DJ, Boguniewicz M, Fonacier L, Grayson MH, Ong PY, Chiesa Fuxench ZC, Simpson EL.

J Invest Dermatol. 2019 Jun;139(6):1388-1391. doi: 10.1016/j.jid.2018.11.029. Epub 2018 Dec 17. No abstract available.

PMID:
30571970
50.

Association Between Oxidation-Modified Lipoproteins and Coronary Plaque in Psoriasis.

Sorokin AV, Kotani K, Elnabawi YA, Dey AK, Sajja AP, Yamada S, Ueda M, Harrington CL, Baumer Y, Rodante JA, Gelfand JM, Chen MY, Joshi AA, Playford MP, Remaley AT, Mehta NN.

Circ Res. 2018 Nov 9;123(11):1244-1254. doi: 10.1161/CIRCRESAHA.118.313608.

Supplemental Content

Loading ...
Support Center